- Home
- MD vs OCUL Comparison
MD vs OCUL Comparison
Compare MD & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MD | OCUL |
|---|---|---|
| Founded | 1979 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hospital/Nursing Management | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.8B |
| IPO Year | 1996 | 2014 |
Fundamental Metrics
Financial Performance| Metric | MD | OCUL |
|---|---|---|
| Price | $23.42 | $9.44 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 9 |
| Target Price | $20.50 | ★ $23.56 |
| AVG Volume (30 Days) | 580.5K | ★ 2.6M |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 263.03 | N/A |
| EPS | ★ 0.36 | N/A |
| Revenue | ★ $1,913,849,000.00 | $1,990,000.00 |
| Revenue This Year | $3.72 | $7.93 |
| Revenue Next Year | $2.62 | $96.07 |
| P/E Ratio | $65.25 | ★ N/A |
| Revenue Growth | N/A | ★ 3.48 |
| 52 Week Low | $11.84 | $6.23 |
| 52 Week High | $24.99 | $16.44 |
Technical Indicators
Market Signals| Indicator | MD | OCUL |
|---|---|---|
| Relative Strength Index (RSI) | 57.63 | 58.37 |
| Support Level | $21.05 | $9.06 |
| Resistance Level | $24.02 | $9.93 |
| Average True Range (ATR) | 0.67 | 0.55 |
| MACD | 0.13 | 0.13 |
| Stochastic Oscillator | 68.82 | 58.61 |
Price Performance
Historical ComparisonAbout MD Pediatrix Medical Group Inc.
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.